Updated clinical and biological information from the two-stage phase II study of imatinib mesylate in subjects with relapsed/refractory neuroblastoma
暂无分享，去创建一个
S. Parodi | M. Ponzoni | A. Moretta | R. Luksch | A. Garaventa | F. Casale | C. Bottino | A. Castellano | R. Castriconi | A. Dondero | F. Morandi | M. Corrias | L. Amoroso